Pateres, Argie .
HRN: 22-02-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
CO-AMOXICLAV 625MG (TAB)
01/14/2023
01/21/2023
PO
1 Cap
BID
COVID 19 RAT Confirmed
Waiting Final Action
Indication: ProphylaxisEmpiricCulture-directed Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes